(Q90576157)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30053872%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

title

Emerging roles of Myc in stem cell biology and novel tumor therapies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30053872%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

1 reference

corrigendum / erratum

Correction to: Emerging roles of Myc in stem cell biology and novel tumor therapies

0 references

author

Go J Yoshida

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30053872%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

publication date

27 July 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30053872%20AND%20SRC:MED&resulttype=core&format=json

Journal of Experimental & Clinical Cancer Research

14 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30053872%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30053872%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30053872%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

page(s)

173

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30053872%20AND%20SRC:MED&resulttype=core&format=json

Identification of nucleotide sequences which may encode the oncogenic capacity of avian retrovirus MC29

14 April 2020

cites work

1 reference

12 December 2020

Effects of the mitotic cell-cycle mutation cdc4 on yeast meiosis

1 reference

12 December 2020

Isolation and characterization of complementary DNA for N-cym, a gene encoded by the DNA strand opposite to N-myc

1 reference

12 December 2020

Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop

1 reference

12 December 2020

Embryonic lethality in mice homozygous for a targeted disruption of the N-myc gene

1 reference

12 December 2020

A targeted mutation reveals a role for N-myc in branching morphogenesis in the embryonic mouse lung

1 reference

12 December 2020

N-myc mRNA forms an RNA-RNA duplex with endogenous antisense transcripts

1 reference

12 December 2020

L-myc cooperates with ras to transform primary rat embryo fibroblasts

1 reference

12 December 2020

Human small-cell lung cancers show amplification and expression of the N-myc gene

1 reference

12 December 2020

Gene amplification of c-myc and N-myc in small cell carcinoma of the lung

1 reference

12 December 2020

Increased expression of N-myc in human small cell lung cancer biopsies predicts lack of response to chemotherapy and poor prognosis

1 reference

12 December 2020

The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice

1 reference

12 December 2020

Structural and kinetic differences between the M2 type pyruvate kinases from lung and various tumors

1 reference

12 December 2020

Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells

1 reference

12 December 2020

Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells

1 reference

12 December 2020

Human neuroblastoma I-type cells are malignant neural crest stem cells

1 reference

12 December 2020

A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice

1 reference

12 December 2020

Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc

1 reference

12 December 2020

Expression and activity of L-Myc in normal mouse development

1 reference

12 December 2020

N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique

1 reference

12 December 2020

c-Myc/Max heterodimers bind cooperatively to the E-box sequences located in the first intron of the rat ornithine decarboxylase (ODC) gene

1 reference

12 December 2020

c-Myc transactivation of LDH-A: implications for tumor metabolism and growth

1 reference

12 December 2020

Interferon-gamma and retinoic acid down-regulate N-myc in neuroblastoma through complementary mechanisms of action

1 reference

12 December 2020

Mechanisms of apoptosis by c-Myc

1 reference

12 December 2020

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group

1 reference

12 December 2020

Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF.

1 reference

12 December 2020

Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc

1 reference

12 December 2020

G6PD deficient cells and the bioreduction of disulfides: effects of DHEA, GSH depletion and phenylarsine oxide

1 reference

12 December 2020

The Myc/Max/Mad network and the transcriptional control of cell behavior

1 reference

12 December 2020

Tumor induction by the c-Myc target genes rcl and lactate dehydrogenase A.

1 reference

12 December 2020

Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.

1 reference

12 December 2020

Identification and characterisation of human xCT that co-expresses, with 4F2 heavy chain, the amino acid transport activity system xc-

1 reference

12 December 2020

Function and regulation of the transcription factors of the Myc/Max/Mad network

1 reference

12 December 2020

All trans retinoic acid in acute promyelocytic leukemia

1 reference

12 December 2020

Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group

1 reference

12 December 2020

Omomyc, a potential Myc dominant negative, enhances Myc-induced apoptosis.

1 reference

12 December 2020

N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation

1 reference

12 December 2020

Cell cycle phase-specific chemotherapy: computational methods for guiding treatment

1 reference

12 December 2020

Neuroblastoma: biological insights into a clinical enigma

1 reference

12 December 2020

Treatment of acute promyelocytic leukemia with ATRA and As2O3: a model of molecular target-based cancer therapy

1 reference

12 December 2020

Functional analysis of the N-terminal domain of the Myc oncoprotein

1 reference

12 December 2020

Retinoid therapy of high-risk neuroblastoma.

1 reference

12 December 2020

On the Origin of Cancer Cells

1 reference

12 December 2020

TUMORS OF NEURAL CREST ORIGIN; BIOCHEMICAL AND PATHOLOGICAL CORRELATION

1 reference

12 December 2020

Progress in treatment of small-cell lung cancer: role of CPT-11.

1 reference

12 December 2020

MYCN in neuronal tumours

1 reference

12 December 2020

Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7

1 reference

12 December 2020

Recognition of phosphodegron motifs in human cyclin E by the SCF(Fbw7) ubiquitin ligase

1 reference

12 December 2020

Tyrosine kinase inhibitors in renal cell carcinoma

1 reference

12 December 2020

A nucleolar isoform of the Fbw7 ubiquitin ligase regulates c-Myc and cell size

1 reference

12 December 2020

LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism.

1 reference

12 December 2020

Regulation of the cell cycle by SCF-type ubiquitin ligases

1 reference

12 December 2020

Pyruvate kinase type M2 and its role in tumor growth and spreading

1 reference

12 December 2020

Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis

1 reference

12 December 2020

Detection of resistance to imatinib by metabolic profiling: clinical and drug development implications

1 reference

12 December 2020

Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway.

1 reference

12 December 2020

Ubiquitin ligases: cell-cycle control and cancer

1 reference

12 December 2020

A phase 2 trial of all-trans-retinoic acid in combination with interferon-alpha2a in children with recurrent neuroblastoma or Wilms tumor: A Pediatric Oncology Branch, NCI and Children's Oncology Group Study

1 reference

12 December 2020

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

1 reference

12 December 2020

The c-Myc target gene network

1 reference

12 December 2020

The transport of glutamine into mammalian cells

1 reference

12 December 2020

Fbw7 isoform interaction contributes to cyclin E proteolysis.

1 reference

12 December 2020

HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity

1 reference

12 December 2020

In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state

1 reference

12 December 2020

Generation of germline-competent induced pluripotent stem cells

1 reference

12 December 2020

Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells.

1 reference

12 December 2020

Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1

1 reference

12 December 2020

Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis

1 reference

12 December 2020

Tumor cell-selective regulation of NOXA by c-MYC in response to proteasome inhibition.

1 reference

12 December 2020

Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts

1 reference

12 December 2020

Widespread microRNA repression by Myc contributes to tumorigenesis

1 reference

12 December 2020

FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation

1 reference

12 December 2020

Pyruvate kinase M2 is a phosphotyrosine-binding protein

1 reference

12 December 2020

The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth

1 reference

12 December 2020

Renal cell carcinoma and the use of sorafenib

1 reference

12 December 2020

Fbxw7 acts as a critical fail-safe against premature loss of hematopoietic stem cells and development of T-ALL.

1 reference

12 December 2020

The oncogene c-Myc coordinates regulation of metabolic networks to enable rapid cell cycle entry

1 reference

12 December 2020

Anoikis resistance and tumor metastasis

1 reference

12 December 2020

Global regulation of nucleotide biosynthetic genes by c-Myc

1 reference

12 December 2020

Notch-dependent cell cycle arrest and apoptosis in mouse embryonic fibroblasts lacking Fbxw7.

1 reference

12 December 2020

Control of nucleotide biosynthesis by the MYC oncoprotein

1 reference

12 December 2020

Transcription-independent functions of MYC: regulation of translation and DNA replication

1 reference

12 December 2020

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

1 reference

12 December 2020

Induced pluripotent stem cells generated without viral integration

1 reference

12 December 2020

Generation of mouse induced pluripotent stem cells without viral vectors

1 reference

12 December 2020

Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas

1 reference

12 December 2020

Reflecting on 25 years with MYC.

1 reference

12 December 2020

Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction

1 reference

12 December 2020

Mcl-1 is a potential therapeutic target in multiple types of cancer

1 reference

12 December 2020

Role of the murine reprogramming factors in the induction of pluripotency

1 reference

12 December 2020

c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism

1 reference

12 December 2020

Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci

1 reference

12 December 2020

Human induced pluripotent stem cells free of vector and transgene sequences

1 reference

12 December 2020

Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon

1 reference

12 December 2020

p53-Altered FBXW7 expression determines poor prognosis in gastric cancer cases.

1 reference

12 December 2020

New clinical developments in histone deacetylase inhibitors for epigenetic therapy of cancer

1 reference

12 December 2020

iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism

1 reference

12 December 2020

MYC-induced cancer cell energy metabolism and therapeutic opportunities

1 reference

12 December 2020

THE METABOLISM OF TUMORS IN THE BODY

1 reference

12 December 2020

Complex regulation of cell-cycle inhibitors by Fbxw7 in mouse embryonic fibroblasts.

1 reference

12 December 2020

Single-cell transcript analysis of human embryonic stem cells.

1 reference

12 December 2020

CD44+ slow-cycling tumor cell expansion is triggered by cooperative actions of Wnt and prostaglandin E2 in gastric tumorigenesis

1 reference

12 December 2020

miR-17-92 cluster: ups and downs in cancer and aging

1 reference

12 December 2020

DNA topoisomerases and their poisoning by anticancer and antibacterial drugs

1 reference

12 December 2020

myc maintains embryonic stem cell pluripotency and self-renewal

1 reference

12 December 2020

Promotion of direct reprogramming by transformation-deficient Myc.

1 reference

12 December 2020

Myc represses primitive endoderm differentiation in pluripotent stem cells.

1 reference

12 December 2020

WD40 Repeat Propellers Define a Ubiquitin-Binding Domain that Regulates Turnover of F Box Proteins

1 reference

12 December 2020

Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets

1 reference

12 December 2020

SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction

1 reference

12 December 2020

CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression

1 reference

12 December 2020

CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth

1 reference

12 December 2020

Oct-4+/Tenascin C+ neuroblastoma cells serve as progenitors of tumor-derived endothelial cells.

1 reference

12 December 2020

Anti-tumour/metastasis effects of the potassium-sparing diuretic amiloride: an orally active anti-cancer drug waiting for its call-of-duty?

1 reference

12 December 2020

Indefinite self-renewal of ESCs through Myc/Max transcriptional complex-independent mechanisms.

1 reference

12 December 2020

MYC and Breast Cancer

1 reference

12 December 2020

The predator becomes the prey: regulating the ubiquitin system by ubiquitylation and degradation

1 reference

12 December 2020

Breaking the cell cycle of HSCs by p57 and friends

1 reference

12 December 2020

p57 Is Required for Quiescence and Maintenance of Adult Hematopoietic Stem Cells

1 reference

12 December 2020

BET bromodomain inhibition as a therapeutic strategy to target c-Myc

1 reference

12 December 2020

Tumor entrained neutrophils inhibit seeding in the premetastatic lung

1 reference

12 December 2020

Role of the ubiquitin ligase Fbw7 in cancer progression

1 reference

12 December 2020

Modulation of glucose metabolism by CD44 contributes to antioxidant status and drug resistance in cancer cells.

1 reference

12 December 2020

Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets

1 reference

12 December 2020

Notch inhibition as a promising new approach to cancer therapy

1 reference

12 December 2020

MYC on the path to cancer

1 reference

12 December 2020

Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC.

1 reference

12 December 2020

Ferroptosis: an iron-dependent form of nonapoptotic cell death

1 reference

12 December 2020

Tumor suppressor functions of FBW7 in cancer development and progression

1 reference

12 December 2020

Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell.

1 reference

12 December 2020

The Role of Mitochondrial NADPH-Dependent Isocitrate Dehydrogenase in Cancer Cells

1 reference

12 December 2020

LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.

1 reference

12 December 2020

Krüppel-like factor 4 (KLF4) suppresses neuroblastoma cell growth and determines non-tumorigenic lineage differentiation.

1 reference

12 December 2020

Pyruvate kinase M2: multiple faces for conferring benefits on cancer cells.

1 reference

12 December 2020

MYCN: from oncoprotein to tumor-associated antigen

1 reference

12 December 2020

ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect

1 reference

12 December 2020

A positive feedback loop regulates the expression of polycomb group protein BMI1 via WNT signaling pathway

1 reference

12 December 2020

Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatment-related neuroendocrine prostate cancer

1 reference

12 December 2020

Role of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases in skin cancer

1 reference

12 December 2020

Genetically engineered mouse models for functional studies of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases

1 reference

12 December 2020

NeuroD1 regulates survival and migration of neuroendocrine lung carcinomas via signaling molecules TrkB and NCAM.

1 reference

12 December 2020

Selective inhibition of tumor oncogenes by disruption of super-enhancers

1 reference

12 December 2020

Molecular regulation of stem cell quiescence.

1 reference

12 December 2020

Histone deacetylase inhibitor potentiated the ability of MTOR inhibitor to induce autophagic cell death in Burkitt leukemia/lymphoma

1 reference

12 December 2020

MYC, metabolism, cell growth, and tumorigenesis.

1 reference

12 December 2020

Control of vertebrate development by MYC

1 reference

12 December 2020

Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target

1 reference

12 December 2020

Targeting neuroblastoma stem cells with retinoic acid and proteasome inhibitor

1 reference

12 December 2020

mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc

1 reference

12 December 2020

Cancer stem cell characteristics, ALDH1 expression in the invasive front of nasopharyngeal carcinoma.

1 reference

12 December 2020

Inversed relationship between CD44 variant and c-Myc due to oxidative stress-induced canonical Wnt activation.

1 reference

12 December 2020

NCYM, a Cis-antisense gene of MYCN, encodes a de novo evolved protein that inhibits GSK3β resulting in the stabilization of MYCN in human neuroblastomas

1 reference

12 December 2020

Regulation of ferroptotic cancer cell death by GPX4

1 reference

12 December 2020

Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer

1 reference

12 December 2020

miR-17-92 cluster targets phosphatase and tensin homology and Ikaros Family Zinc Finger 4 to promote TH17-mediated inflammation

1 reference

12 December 2020

Roles of F-box proteins in cancer

1 reference

12 December 2020

Myc and cell cycle control.

1 reference

12 December 2020

MYC and mitochondrial biogenesis

1 reference

12 December 2020

Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis

1 reference

12 December 2020

Role of Fbxw7 in the maintenance of normal stem cells and cancer-initiating cells

1 reference

12 December 2020

Regulation and Role of EZH2 in Cancer

1 reference

12 December 2020

c-Myc programs fatty acid metabolism and dictates acetyl-CoA abundance and fate

1 reference

12 December 2020

Metabolic characterization of triple negative breast cancer

1 reference

12 December 2020

F-box protein FBXW7 inhibits cancer metastasis in a non-cell-autonomous manner

1 reference

12 December 2020

Deregulated Myc requires MondoA/Mlx for metabolic reprogramming and tumorigenesis

1 reference

12 December 2020

Functional interplay between MYCN, NCYM, and OCT4 promotes aggressiveness of human neuroblastomas

1 reference

12 December 2020

Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis.

1 reference

12 December 2020

Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma.

1 reference

12 December 2020

The c-Myc-LDHA axis positively regulates aerobic glycolysis and promotes tumor progression in pancreatic cancer

1 reference

12 December 2020

Regulating the Regulators: Recent Revelations in the Control of E3 Ubiquitin Ligases

1 reference

12 December 2020

Bortezomib inhibits Burkitt's lymphoma cell proliferation by downregulating sumoylated hnRNP K and c-Myc expression

1 reference

12 December 2020

Therapeutic strategies targeting cancer stem cells

1 reference

12 December 2020

Fbw7 and its counteracting forces in stem cells and cancer: Oncoproteins in the balance

1 reference

12 December 2020

Clinical development of cancer therapeutics that target metabolism

1 reference

12 December 2020

Metabolic reprogramming: the emerging concept and associated therapeutic strategies

1 reference

12 December 2020

Bmi-1: At the crossroads of physiological and pathological biology

1 reference

12 December 2020

Dysregulated metabolism contributes to oncogenesis

1 reference

12 December 2020

Regulating Fbw7 on the road to cancer

1 reference

12 December 2020

Reactivation of p53 via MDM2 inhibition

1 reference

12 December 2020

Glutaminolysis as a target for cancer therapy

1 reference

12 December 2020

Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer

1 reference

12 December 2020

Myc Depletion Induces a Pluripotent Dormant State Mimicking Diapause

1 reference

12 December 2020

The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis.

1 reference

12 December 2020

Clinical and Biologic Significance of MYC Genetic Mutations in De Novo Diffuse Large B-cell Lymphoma

1 reference

12 December 2020

Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer

1 reference

12 December 2020

PKM2 and cancer: The function of PKM2 beyond glycolysis

1 reference

12 December 2020

Mechanisms of ferroptosis

1 reference

12 December 2020

N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells

1 reference

12 December 2020

BET Bromodomain Inhibition Releases the Mediator Complex from Select cis-Regulatory Elements

1 reference

12 December 2020

To wake up cancer stem cells, or to let them sleep, that is the question

1 reference

12 December 2020

The secret life of quiescent cancer stem cells

1 reference

12 December 2020

A c-Myc/miR17-92/Pten Axis Controls PI3K-Mediated Positive and Negative Selection in B Cell Development and Reconstitutes CD19 Deficiency.

1 reference

12 December 2020

Potential Roles of Amiloride-Sensitive Sodium Channels in Cancer Development

1 reference

12 December 2020

Cancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer Therapy

1 reference

12 December 2020

N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer

1 reference

12 December 2020

OmoMYC blunts promoter invasion by oncogenic MYC to inhibit gene expression characteristic of MYC-dependent tumors

1 reference

12 December 2020

The Warburg Effect and the Hallmarks of Cancer.

1 reference

12 December 2020

The Warburg effect: 80 years on

1 reference

12 December 2020

Prognostic impact of CD44-positive cancer stem-like cells at the invasive front of gastric cancer

1 reference

12 December 2020

Targeting metastasis-initiating cells through the fatty acid receptor CD36

1 reference

12 December 2020

Glutaminolysis gets the spotlight in cancer

1 reference

12 December 2020

MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition.

1 reference

12 December 2020

The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia

1 reference

12 December 2020

E3 ubiquitin ligase FBW7α inhibits cholangiocarcinoma cell proliferation by downregulating c-Myc and cyclin E.

1 reference

12 December 2020

Therapeutic strategies of drug repositioning targeting autophagy to induce cancer cell death: from pathophysiology to treatment.

1 reference

12 December 2020

Strategies to Inhibit Myc and Their Clinical Applicability

1 reference

12 December 2020

The heterogeneity of cancer stem-like cells at the invasive front

1 reference

12 December 2020

Proteasome expression and activity in cancer and cancer stem cells

1 reference

12 December 2020

Genetic profiling of MYC and BCL2 in diffuse large B-cell lymphoma determines cell-of-origin-specific clinical impact.

1 reference

12 December 2020

Glutaminase inhibitor CB-839 synergizes with carfilzomib in resistant multiple myeloma cells

1 reference

12 December 2020

Enzyme-substrate relationships in the ubiquitin system: approaches for identifying substrates of ubiquitin ligases

1 reference

12 December 2020

Targeting Free Radicals in Oxidative Stress-Related Human Diseases

1 reference

12 December 2020

ATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner

1 reference

12 December 2020

Treatment advances in small cell lung cancer (SCLC).

1 reference

12 December 2020

Biology and evolution of poorly differentiated neuroendocrine tumors.

1 reference

12 December 2020

Global metabolic reprogramming of colorectal cancer occurs at adenoma stage and is induced by MYC.

1 reference

12 December 2020

Administering xCT Inhibitors Based on Circadian Clock Improves Antitumor Effects.

1 reference

12 December 2020

Proteasome-associated deubiquitinases and cancer

1 reference

12 December 2020

Characterization of the interactions of potent allosteric inhibitors with glutaminase C, a key enzyme in cancer cell glutamine metabolism.

1 reference

12 December 2020

A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment.

1 reference

12 December 2020

p53 Suppresses Metabolic Stress-Induced Ferroptosis in Cancer Cells.

1 reference

12 December 2020

The Expanding World of N-MYC-Driven Tumors.

1 reference

12 December 2020

Glutamine Transport and Mitochondrial Metabolism in Cancer Cell Growth.

1 reference

12 December 2020

Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis.

1 reference

12 December 2020

The Epithelial Sodium Channel (αENaC) Is a Downstream Therapeutic Target of ASCL1 in Pulmonary Neuroendocrine Tumors.

1 reference

12 December 2020

MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like state.

1 reference

12 December 2020

Targeting oncogenic Myc as a strategy for cancer treatment

1 reference

12 December 2020

PKM1 Confers Metabolic Advantages and Promotes Cell-Autonomous Tumor Cell Growth.

1 reference

12 December 2020

Current and future therapeutic approaches for the treatment of small cell lung cancer.

1 reference

12 December 2020

Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas.

1 reference

12 December 2020

Thymidine phosphorylase in cancer aggressiveness and chemoresistance

1 reference

12 December 2020

Prevention of hepatocellular carcinoma by targeting MYCN-positive liver cancer stem cells with acyclic retinoid.

1 reference

12 December 2020

Enhancer reprogramming in tumor progression: a new route towards cancer cell plasticity

1 reference

12 December 2020

MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma.

1 reference

12 December 2020

How to eliminate MYCN-positive hepatic cancer stem cells to prevent the recurrence?

1 reference

12 December 2020

10.1186/S13046-018-0835-Y

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30053872%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30053872%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

1 reference